Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Cash & Equivalents Over TimeStrong
Percentile Rank79
3Y CAGR-2.2%
5Y CAGR+51.1%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-2.2%/yr
vs +45.4%/yr prior
5Y CAGR
+51.1%/yr
Recent deceleration
Acceleration
-47.6pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
7.9x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $72.90M | -4.9% |
| 2023 | $76.68M | -29.6% |
| 2022 | $108.91M | +39.9% |
| 2021 | $77.83M | +22.4% |
| 2020 | $63.61M | +587.4% |
| 2019 | $9.25M | -32.3% |
| 2018 | $13.67M | -21.4% |
| 2017 | $17.40M | -15.2% |
| 2016 | $20.52M | -20.0% |
| 2015 | $25.64M | - |